Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
Journal: European urology
Published: May 19, 2018
PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT).
Journal: Clinical and translational radiation oncology
Published: March 06, 2018
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making.
Journal: JCO precision oncology
Published: August 22, 2017
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Journal: Nature genetics
Published: August 18, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.
Journal: Cancer discovery
Published: November 29, 2016
RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 15, 2014
TGF-β induction of FGF-2 expression in stromal cells requires integrated smad3 and MAPK pathways.
Journal: American journal of clinical and experimental urology
Published: September 15, 2014
WFDC1 is a key modulator of inflammatory and wound repair responses.
Journal: The American journal of pathology
Published: May 11, 2014
Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.
Journal: The American journal of pathology
Published: December 24, 2013
The reactive stroma microenvironment and prostate cancer progression.
Journal: Endocrine-related cancer
Published: August 30, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026